Business
Change of Adviser
Change of Adviser.
About this update from Fortis Frontier Plc
[{"type":"text","content":"\n \n \n RNS Number : 6811T\n Concepta PLC\n 22 July 2020\n \n \n \n \n Concepta PLC\n \n \n (\"Concepta\" or the \"Company\") \n \n \n \n Change of Adviser \n \n \n \n \n \n Concepta PLC (AIM: CPT), the personalised healthcare company, announces the appointment of\n Oberon Capital, part of the Oberon Investments Ltd group, as \n joint broker with immediate effect.\n \n \n \n \n \n \n \n \n Concepta plc\n \n \n \n \n \n \n www.conceptaplc.com\n \n \n \n \n \n \n \n \n P\n enny McCormick\n , Chief Executive Officer\n \n \n \n \n via Walbrook PR\n \n \n \n \n \n \n Maddy Kennedy, Chief Financial Officer\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n SPARK Advisory Partners Limited (NOMAD)\n \n \n \n \n Tel: +44 (0)20 3368 3550\n \n \n \n \n \n \n Neil Baldwin \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Novum Securities (Joint Broker)\n \n \n \n \n Tel: +44 (0)20 7399 9400\n \n \n \n \n \n \n Colin Rowbury\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Oberon Capital Ltd (Joint Broker)\n \n \n \n \n Tel: +44 (0)203 179 5344\n \n \n \n \n \n \n Mike Seabrook\n \n \n \n \n \n [email protected]\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Walbrook PR Ltd (Media & Investor Relations)\n \n \n \n \n Tel: +44 (0)20 7933 8780 or \n \n \n [email protected]\n \n \n \n \n \n \n \n \n Paul McManus\n \n \n \n \n Mob: +44(0)7980 541 893 \n \n \n \n \n \n \n \n \n \n \n \n \n About Concepta PLC\n \n \n (\n \n \n \n www.conceptaplc.com\n \n \n \n ) \n \n \n \n \n \n \n Concepta PLC is an AIM-quoted pioneering UK healthcare company that has developed a proprietary product MYLO, targeted at the personalized mobile health market with a primary focus on hormone testing and increasing a woman's chances of naturally getting pregnant and to provide insight to unexplained infertility.\n \n \n \n \n \n \n MYLO is currently the only consumer product which allows both quantitative and qualitative home (self-test) test measurement of a woman's personal luteinizing hormone (LH) during ovulation and human chorionic gonadotropin (hCG) hormone level during pregnancy, facilitating higher conception rates and early diagnosis of ferti...